U.S. Food and Drug Administration · FDA enforcement report entry
FDA Class II: Reliance Life Sciences Private Limited — Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Int
The U.S. Food and Drug Administration listed this entry in its enforcement reports on July 15, 2026. The source link opens the FDA’s recalls, market withdrawals and safety alerts page.
Read the official source on fda.gov →
- Issued by
- U.S. Food and Drug Administration
- Document type
- FDA enforcement report entry
- Date
- First recorded by CourtPulse
- · all records that day
- Category
- FDA action
CourtPulse lists public records with a link to the official source. The title is shown as the source published it; this page adds no commentary.